On December 28, 2023, Cytogen, Inc. closed the transaction. The company received KRW 15,500,000,000 for series 5 bonds in its second and final tranche closing.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,250 KRW | 0.00% | -9.93% | -16.79% |
1st Jan change | Capi. | |
---|---|---|
-16.79% | 184M | |
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited